Facebook Twitter Instagram
    Sunday, January 29
    • Home
    • Affiliate Disclosure
    • FTC Statement
    • Privacy Policy
    • Disclaimer
    Facebook Twitter Instagram LinkedIn
    Cannabis illumination
    Green 85
    • Home
    • Cannabis Media

      Grow Sisters Media, High NOON Sundays Podcast with LeafWorks, Cannabis Feminized Seed Certification

      January 28, 2023

      Cannabis Club, October 26, 2022

      January 27, 2023

      Blissco Cannabis updates investors

      January 26, 2023

      Nextleaf Solutions granted patent in Mexico as country legalizes adult-use cannabis

      January 25, 2023

      Cannabis Canada Weekly: Tilray's CEO wants Ottawa to take action on pot file

      January 24, 2023
    • Cannabis News

      Canadian resident arrested in relation to massive cannabis bust at U.S. border – TV9

      January 28, 2023

      ‘Miracle’: See impact marijuana had on autistic girl

      January 27, 2023

      This Week in Cannabis News – Sept 13 to Sept 19 2021

      January 26, 2023

      8 U.S. schools offering degrees in cannabis

      January 25, 2023

      South Africa's first legal cannabis pharmacy: Govt backs cannabis for medicinal use | WION

      January 24, 2023
    • Cannabis Products

      Bigger Yields in Less Space – Complete Cannabis Training Guide

      January 28, 2023

      High street cannabis products and the complexity of cannabis law

      January 27, 2023

      Inside 7ACRES by Supreme Cannabis Company: A Cannabis Licensed Producer in Canada

      January 26, 2023

      Is Cannabis Now Legal In Australia?

      January 25, 2023

      UK’s first medical cannabis clinic opens in Greater Manchester

      January 24, 2023
    • Shop
    Cannabis illumination
    You are at:Home»Blog»Congress passes ‘CBD and Marihuana Research Expansion Act’

    Congress passes ‘CBD and Marihuana Research Expansion Act’

    Facebook Twitter Pinterest LinkedIn Tumblr Email
    Share
    Facebook Twitter LinkedIn Pinterest Email
    Green 85


    Tens of millions of medical patients who could benefit from new, FDA-approved prescription CBD got the tiniest of breaks from Congress Monday.

    The US House of Representatives voted this evening to pass the Cannabidiol and Marihuana Research Expansion Act, which is intended to allow new drug research and development. The Senate voted unanimously to pass the bill in March.

    Doctors have reported for decades that marijuana’s federal Schedule I status—designating it as a drug as dangerous as heroin—blocks basic drug trials. A generation of patients has undertaken those trials on themselves. (Ninety-two percent of medical cannabis users reported efficacy in one state survey in 2014.)

    Currently, 38 states have legalized cannabis medically or for all adults, yet ‘marijuana’ remains a Schedule I substance.

    The new Act—sponsored by Sen. Dianne Feinstein (D-CA), Sen. Chuck Grassley (R-IA), and eight other senators—doesn’t change weed’s Schedule I status. But it does force the federal government to allow more researchers to grow medical cannabis, and allows doctors to talk about pot without fear of losing their medical license, as well as other modest tweaks.

    About 91% of Americans support medical marijuana legalization, Pew Research finds. Yet the CBD research expansion act came up for a vote, passed and then died in 2020.

    The House of Representatives also passed a full-scale legalization bill—the MORE Act—last week.

    About 68% of Americans support full legalization. But Sen. Feinstein—a long-serving Democrat representing the largest legal cannabis market on the planet, which did $5.1 billion in legal sales last year—is focused on further research, not legalizing it federally.

    Related

    The Dianne Feinstein Mystery: Why Is She California’s Last Prohibitionist?

    “Current rules and regulations make it hard for researchers to study how marijuana and marijuana-derived medications can best be used to treat various conditions,” said Sen. Feinstein, in a release. “This important legislation will cut the red tape around the research process, helping get FDA-approved, marijuana-derived medications safely to patients.”

    Policy experts note that marijuana has been studied for decades, and has shown medical efficacy, with a lower abuse profile than prescription drugs. And yet Republican Sen. Grassley cheered the chance for more such research in a release.

    Related

    Congress just legalized marijuana via the MORE Act—again.

    “This bipartisan bill is critical to better understanding the marijuana plant and its potential benefits and side effects,” Grassley said in a statement. “It will empower the FDA to analyze CBD and medical marijuana products in a safe and responsible way so that the American public can decide whether to utilize them in the future based on sound scientific data. Researching marijuana is widely supported by my colleagues on both sides of the aisle, and it’s a smart step forward in addressing this current Schedule I drug.”

    David Downs's Bio Image

    David Downs

    David Downs directs news and lifestyle coverage as the California Bureau Chief for Leafly.com. He’s written for WIRED, Rolling Stone and Billboard, and is the former cannabis editor of the San Francisco Chronicle, as well as the author of several cannabis books including ‘Marijuana Harvest’ by Ed Rosenthal and David Downs. He co-hosts The Hash podcast. TW: @davidrdowns | IG @daviddowns

    View David Downs’s articles

    By submitting this form, you will be subscribed to news and promotional emails from Leafly and you agree to Leafly’s Terms of Service and Privacy Policy. You can unsubscribe from Leafly email messages anytime.

    Green 85
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Previous ArticleGrowing Cannabis From Clones
    Next Article USA: Gratis-Cannabis für Geimpfte | DHV-News # 290

    Related Posts

    Did Twitch ban top streamer Kai Cenat for dozing off after weed edibles?

    January 28, 2023

    21 ways to save money on weed

    January 27, 2023

    Huge decision: FDA won’t restrict CBD sales, calls for ‘new regulatory pathway’ to assure safety

    January 26, 2023
    Green 85
    Recent Posts
    • Canadian resident arrested in relation to massive cannabis bust at U.S. border – TV9
    • Grow Sisters Media, High NOON Sundays Podcast with LeafWorks, Cannabis Feminized Seed Certification
    • Bigger Yields in Less Space – Complete Cannabis Training Guide
    • Did Twitch ban top streamer Kai Cenat for dozing off after weed edibles?
    • ‘Miracle’: See impact marijuana had on autistic girl
    Green 85
    Don't Miss

    Canadian resident arrested in relation to massive cannabis bust at U.S. border – TV9

    Grow Sisters Media, High NOON Sundays Podcast with LeafWorks, Cannabis Feminized Seed Certification

    Bigger Yields in Less Space – Complete Cannabis Training Guide

    Did Twitch ban top streamer Kai Cenat for dozing off after weed edibles?

    Popular Posts

    Canadian resident arrested in relation to massive cannabis bust at U.S. border – TV9

    January 28, 2023

    Grow Sisters Media, High NOON Sundays Podcast with LeafWorks, Cannabis Feminized Seed Certification

    January 28, 2023

    Bigger Yields in Less Space – Complete Cannabis Training Guide

    January 28, 2023
    Recent Posts
    • Canadian resident arrested in relation to massive cannabis bust at U.S. border – TV9
    • Grow Sisters Media, High NOON Sundays Podcast with LeafWorks, Cannabis Feminized Seed Certification
    • Bigger Yields in Less Space – Complete Cannabis Training Guide
    • Did Twitch ban top streamer Kai Cenat for dozing off after weed edibles?
    • ‘Miracle’: See impact marijuana had on autistic girl
    Latest Posts

    New York Marijuana Legalization Bill Signed By Governor Cuomo

    April 1, 2021

    As 4/20 Passes, The Inequalities In Cannabis Policy Are Still Evident

    April 21, 2021

    NFL Marijuana Testing Drastically Scaled Back Under New CBA

    April 30, 2021
    Copyright © 2023. FOR SALE: This Domain & Website is For Sale. Please Call 360 256-1117 or Email thewaymarketing88@gmail.com For All the Details.

    Type above and press Enter to search. Press Esc to cancel.